Culture, Medicine, and Psychiatry

, Volume 34, Issue 1, pp 2–12 | Cite as

Bad Medicine: There Is a Lot Wrong with Diabetes Care in the United States



  1. The Action to Control Cardiovascular Risk in Diabetes Study Group 2008 Effects of Intensive Glucose Lowering in Type 2 Diabetes. New England Journal of Medicine 358(24):2545–2559.CrossRefGoogle Scholar
  2. Barnes, Patricia M., Barbara Bloom, and Richard L. Nahin 2008 Complementary and Alternative Medicine Use among Adults and Children: United States, 2007. National Health Statistics Report 12:1–23.Google Scholar
  3. Chalmers, John, and Mark E. Cooper 2008 UKPDS and the Legacy Effect. New England Journal of Medicine 359(15):1618–1620.CrossRefGoogle Scholar
  4. Chiasson, Jean-Louis, Robert G. Josse, Ramon Gomis, Markolf Hanefield, et al. 2002 Acarbose for Prevention of Type 2 Diabetes Mellitus: The STOP-NIDDM Randomized Trial. Lancet 359(9323):2072–2077.CrossRefGoogle Scholar
  5. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group 2000 Retinopathy and Nephropathy in Patients with Type 1 Diabetes Four Years after a Trial of Intensive Therapy. New England Journal of Medicine 342(6):381–389.CrossRefGoogle Scholar
  6. The Diabetes Control and Complications Trial Research Group 1993 The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus. New England Journal of Medicine 329(14):977–986.CrossRefGoogle Scholar
  7. Diabetes Prevention Program Research Group 2002 Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. New England Journal of Medicine 346(6):393–403.CrossRefGoogle Scholar
  8. The DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators 2006 Effect of Rosiglitazone on the Frequency of Diabetes in Patients with Impaired Glucose Tolerance or Impaired Fasting Glucose: A Randomized Controlled Trial. Lancet 368(9541):1096–1105.CrossRefGoogle Scholar
  9. Gale, Edwin A. M. 2006 Declassifying Diabetes. Diabetalogia 49(9):1989–1995.CrossRefGoogle Scholar
  10. Gulati, Martha, Dilip K. Pandey, Morton F. Arnsdorf, Diane S. Lauderdale, et al. 2003 Exercise Capacity and the Risk of Death in Women: The St James Women Take Heart Project. Circulation 108(13):1554–1559.CrossRefGoogle Scholar
  11. Haffner, Steven M., Seppo Lehto, Tapani Ronnemaa, Kalevi Pyorala, and Markku Laakso 1998 Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction. New England Journal of Medicine 339(4):229–234.CrossRefGoogle Scholar
  12. Joslin, Elliott P. 1959 Diabetic Manual. 10th ed. Philadelphia: Lea & Febiger.Google Scholar
  13. The Look AHEAD Research Group 2007 Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals with Type 2 Diabetes: The One-Year Results of the Look AHEAD Trial. Diabetes Care 30(6):1374–1383.CrossRefGoogle Scholar
  14. Myers, Jonathan, Manish Prakash, Victor Froelicher, Dat Do, et al. 2002 Exercise Capacity and Mortality among Men Referred for Exercise Testing. New England Journal of Medicine 346(11):793–801.CrossRefGoogle Scholar
  15. Romon, Monique, Agnes Lommez, Muriel Tafflet, Arnaud Basdevant, et al. 2008 Downward Trends in the Prevalence of Childhood Overweight in the Setting of 12-Year School- and Community-Based Programmes. Public Health Nutrition. Online. doi: 10.1017/S1368980008004278.
  16. Sacks, Frank M., George A. Bray, Vincent J. Carey, Steven R. Smith, et al. 2009 Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates. New England Journal of Medicine 360(9):859–873.CrossRefGoogle Scholar
  17. Shetty, Sharashchandra, Kristin Secnik, and Alan Oglesby 2005 Relationship of Glycemic Control to Total Diabetes-Related Costs for Managed Care Health Plan Members with Type 2 Diabetes. Journal of Managed Care Pharmacy 11(7):559–564.Google Scholar
  18. Tuomilheto, Jaako, Jaana Lindstrom, Johan G. Eriksson, Timo T. Valle, et al., for the Finnish Diabetes Prevention Study Group 2001 Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle Among Subjects with Impaired Glucose Tolerance. New England Journal of Medicine 344(18): 1343–1350.Google Scholar
  19. UK Prospective Diabetes Study (UKPDS) Group 1998 Intensive Blood-Glucose Control with Sulphonylureas or Insulin Compared with Conventional Treatment and Risk of Complications in Patients with Type 2 Diabetes (UKPDS 33). Lancet 352(9131):837–853.CrossRefGoogle Scholar
  20. United Nations General Assembly 2006 United Nations Resolution 61/225. Adapted at 83rd plenary meeting of the UN General Assembly.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.North Coast Institute of Diabetes and Endocrinology, Inc.WestlakeUSA
  2. 2.Department of MedicineCase Western Reserve UniversityClevelandUSA

Personalised recommendations